131 related articles for article (PubMed ID: 773334)
1. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
[TBL] [Abstract][Full Text] [Related]
2. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
Günther J
Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
[TBL] [Abstract][Full Text] [Related]
3. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
Harlos JP; Weiss L
Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
[TBL] [Abstract][Full Text] [Related]
4. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
Fike RM; van Oss CJ
Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests.
Shenton BK; Jenssen HL; Werner H; Field EJ
J Immunol Methods; 1977; 14(2):123-39. PubMed ID: 138709
[TBL] [Abstract][Full Text] [Related]
6. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
[TBL] [Abstract][Full Text] [Related]
7. Cellular immunity to human basic myelin protein in women with dysplasia and carcinoma in situ of the cervix.
Singer A; Shelton J; Hill S; Potter C
Br J Obstet Gynaecol; 1975 Oct; 82(10):820-5. PubMed ID: 53067
[TBL] [Abstract][Full Text] [Related]
8. The macrophage electrophoretic mobility (MEM) test--an investigation of its value as a routine laboratory test in the detection of malignant disease.
Pritchard JA; Sutherland WH; Teasdale C; Whitehead RH; Deeley TJ; Hughes LE
Ann Clin Res; 1978 Apr; 10(2):71-4. PubMed ID: 354473
[TBL] [Abstract][Full Text] [Related]
9. Immunodiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignancies.
Douwes FR; Hoffmann W; Mross K
Oncology; 1977; 34(2):80-3. PubMed ID: 70771
[TBL] [Abstract][Full Text] [Related]
10. The assessment of histocompatibility by mixed lymphocyte reaction as measured by the macrophage electrophoretic mobility (MEM) test.
Shenton BK; Uldall PR; Swinney J; Field EJ
Tissue Antigens; 1975 May; 5(4):246-56. PubMed ID: 125469
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to encephalitogenic factor (MMI test) in women with cervical dysplasia and carcinoma in situ: the effects of serum.
Flavell DJ; Singer A; Potter CW
Br J Cancer; 1978 Sep; 38(3):396-400. PubMed ID: 81675
[TBL] [Abstract][Full Text] [Related]
12. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
Crozier EH; Hollinger ME; Woodend BE; Robertson JH
J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
[TBL] [Abstract][Full Text] [Related]
13. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
Glaves D; Harlos JP; Weiss L
Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
[TBL] [Abstract][Full Text] [Related]
14. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Hoffmann W; Werner W; Steiner R; Kaufmann R
Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
[TBL] [Abstract][Full Text] [Related]
15. [The electrophoresis mobility (em) test in cervical-intra-epithelial neoplasia (c.i.n.) (author's transl)].
Bögelspacher HR; Tautz C; Geppert M
Geburtshilfe Frauenheilkd; 1980 Jun; 40(6):545-9. PubMed ID: 7409420
[TBL] [Abstract][Full Text] [Related]
16. The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report.
Klausch B; Straube W; Hofmann R; Büttner HH; Jenssen HL; Köhler H; Günther J
Ann Chir Gynaecol; 1977; 66(4):209-13. PubMed ID: 71873
[TBL] [Abstract][Full Text] [Related]
17. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
[TBL] [Abstract][Full Text] [Related]
18. Macrophage electrophoretic mobility (MEM) with myelin basic protein.
Rawlins GA; Wood JM; Bagshawe KD
Br J Cancer; 1976 Dec; 34(6):613-8. PubMed ID: 1008988
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen in patients with gynecologic malignancies.
DiSaia PJ; Haverback BJ; Dyce BJ; Morrow CP
Am J Obstet Gynecol; 1975 Jan; 121(2):159-63. PubMed ID: 163585
[TBL] [Abstract][Full Text] [Related]
20. Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer; 1976 Jul; 34(1):1-6. PubMed ID: 60118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
